I don’t doubt that there have been low-ball offers that Joe has turned down for one or another of the subsidiaries. I can also see that...from his point of view...we are too close to the finish line to sell now. I wouldn’t want him to sell NGIO at this point, or Olaregen or Altucell. But the waiting...geeez, the waiting...
Generex Biotechnology Corp. (GNBT) Stock Research Links